학술논문
Cost-effectiveness analysis of sintilimab plus IBI305 versus sorafenib for unresectable hepatic cell carcinoma in China
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, July 2023, 12(14):14871-14880)
Subject
Language
English
ISSN
20457634